共 50 条
- [1] Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years Osteoporosis International, 2013, 24 : 301 - 310
- [2] Clinical utility of risedronate in postmenopausal osteoporosis: patient considerations with delayed-release formulation INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2012, 4 : 167 - 174
- [5] Delayed-Release Risedronate (Atelvia) MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2011, 53 (1360): : 24 - 24
- [6] Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tablet Osteoporosis International, 2012, 23 : 267 - 276
- [10] Comparison of weekly treatment of postmenopausal osteoporosis with alendronate versus risedronate over two years JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (07): : 2631 - 2637